SUMISEI-SBI
Minato, Chiba, Japan, Asia
Overview
SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator". SBI Investment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 1
- Active investors
- 8
Sector focus
- Finance
- Financial Services
- Venture Capital
Investment portfolio
- LIFESCAPES
Participated · Equity · Jun 2026
LIFESCAPES is a Keio University spinout founded in May 2018 and led by CEO Junichi Ushiba that develops medical devices leveraging brain-machine interface (BMI/BCI) technology to treat severe hand and arm paralysis caused by stroke and other central nervous system diseases. The company has secured regulatory approval in Malaysia and began an initial deployment with PERKESO, the Malaysian social security organization. In December 2025 Japan's Ministry of Health, Labour and Welfare designated its tentative "LIFESCAPES Therapeutic BMI" device as a "Pioneering Medical Device," enabling planned investigator-initiated clinical trials in summer 2026 to verify safety and efficacy. LIFESCAPES raised ¥600 million in its recent third-party allotment to fund ASEAN and North American expansion, domestic clinical trials, and private-pay services for chronic-phase patients. The company aims to establish sales networks in Singapore, Indonesia, and Thailand within fiscal 2026 and pursue broader international commercialization. The funding and regulatory milestones position LIFESCAPES to transition from research to commercial medical device deployment.